Improved Multiple Sclerosis Lesion Detection using an Intelligent Automation Software - Federau, Christian; Hainc, Nicolin; Edjlali, Myriam; Zhu, Guangming; Mastilovic, Milica; Nierobisch, Nathalie; Uhlemann, Jan-Philipp; Paganucci, Silvio; Granziera, Cristina; Heinzlef, Olivier; Kipp, Lucas B.; Wintermark, Max (medRxiv, 2023)
Introduction The assessment of multiple sclerosis (MS) lesions on follow-up magnetic resonance imaging (MRI) is tedious, time-consuming, and error-prone. Automation of low-level tasks could enhance the radiologist in this work. We evaluate the intelligent automation software Jazz in a blinded three centers study, for the assessment of new, slowly expanding, and contrast-enhancing MS lesionsMethods In three separate centers, 117 MS follow-up MRIs were blindly analyzed on FLuid Attenuated Inversion Recovery (FLAIR), pre- and post-Gadolinium T1-weighted images using Jazz by 2 neuroradiologists in each center. The reading time was recorded. The ground truth was defined in a second reading by side-by-side comparison of both reports from Jazz and the standard clinical report. The number of described new, slowly expanding, and contrast-enhancing lesions described with Jazz was compared to the lesions described in the standard clinical report.Results A total of 96 new lesions from 41 patients and 162 slowly expanding lesions (SELs) from 61 patients were described in the ground truth reading. A significantly larger number of new lesions were described using Jazz compared to the standard clinical report (63 versus 24). No SELs were reported in the standard clinical report, while 95 SELs were reported on average using Jazz. A total of 4 new contrast-enhancing lesions were found in all reports. The reading with Jazz was very time efficient, taking on average 2min33sec extpm 1min0sec per case. Overall inter-reader agreement for new lesions between the readers using Jazz was moderate for new lesions (Cohen kappa=0.5) and slight for SELs (0.08).Discussion The quality and the productivity of neuroradiological reading of MS follow-up MRI scans can be significantly improved using a dedicated software such as Jazz.Competing Interest StatementChristian Federau is the founder and CEO of AI Medical AG Silvio Paganucci is employee and stock holder of AI Medical AGFunding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethic committee of the Canton of ZuerichI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors